XON News and Press, Intrexon Corporation From 11/12/19

GERMANTOWN, Md. , Nov. 12, 2019 /PRNewswire/ --  Intrexon Corporation  (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced its third quarter financial results for 2019. Re...

Intrexon (NASDAQ: XON ) is scheduled to announce Q3 earnings results on Tuesday, November 12th, before market open. The consensus EPS Estimate is -$0.22 (+50.0% Y/Y) and the consensus Revenue Estimate is $33M (+1.9% Y/Y). Over the last 2 years, XON  has beaten EPS estimates 38% o...

AAP , ACM , AEIS , BPMP , CBS , CNNE , CRON , CVET , DF , DHI , DPLO , DSKE , EBIX , EDIT , EGRX , EPC , ERJ , GTT , IAA , IIVI , INFN , KEM , MPAA , OSTK , PSN , RDNT , ROK , SAGE , SE , TSN , XON For Seeking Alpha's full earnings season calendar, click ...

GERMANTOWN, Md. , Nov. 7, 2019 /PRNewswire/ -- Triple-Gene LLC , a clinical stage cardiovascular gene therapy company and majority owned subsidiary of Intrexon Corporation (NASDAQ: XON), today announced the completion of enrollment and dosing in its Phase 1 trial of INXN-4001, a multigen...

GERMANTOWN, Md. , Nov. 4, 2019 /PRNewswire/ -- Intrexon Corporation  (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced it will release third quarter financial results before the market...

Intrexon ( XON -2% ) discloses the sale of its stake of 8,239,199 common shares of bioengineered salmon producer AquaBounty Technologies ( AQB -1.7% ) to TS Aquaculture, LLC, a privately held company managed by Third Security, LLC , a venture capital firm led by Intrexon Chairman &...

In our most recent article, we focused on Iovance ( IOVA ), a cell therapy company that in our opinion has consistently generated positive data, has developed a commercializable product, and is deploying a de-risked clinical strategy for a clear unmet need. As a result, we saw nearly 100% ups...

GERMANTOWN, Md., Sept. 26, 2019 /PRNewswire/ -- Intrexon Corporation  (NASDAQ: XON), a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet, today announced David H. Witte's acceptance as Chief Executive Officer des...

VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) ("Next Green Wave", “NGW” or the "Company") announces that it has completed the installation and activation of its research and innovation laboratory ...

Intrexon Corporation ( XON ) has been on an interesting ride this year, starting the year in the $7/share range before dropping massively to $4-5/share, recovering back to the $8 range after an insider buying spree from the CEO during late spring/early summer, and now dropping again to the nea...